Specifying Non-Viable Particle Monitoring for Aseptic Processing

Major pharmaceutical companies are investing in new biologics, most of which will be manufactured using aseptic processing. Continuous non-viable particle monitoring (NVP), when properly configured, provides useful information on changes in the aseptic environment with minute-by-minute updates of count populations and trends, which catch contamination events and thereby identify and quantify risks  (i.e. a non-zero result). Both the FDA and EU specifically reference continuous monitoring of NVP during aseptic processing for the purpose of real time event detection. This paper gives an overview of the trends, best practices and tips to consider when setting up an NVP monitoring system.

Download this whitepaper & learn about:

  • Get a head start on the best practices and trends to set up a non-viable particle monitoring system
  • Get details of the key considerations when implementing an NVP system
  • Get started on putting together a User Requirements Specification
  • Get useful tips on starting early rather than bolting on an NVP system

Fill the form below to download now.

    This is co-hosted by Express Pharma and Beckman Coulter Life Sciences

    By submitting this form, you are confirming you are an adult 18 years or older and agree to Express Pharma contacting you with marketing-related emails or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.

    Comments (0)
    Add Comment